Furthermore, we find that pharmacological activation of AMPK using a potent and specific direct AMPK activator, BI9774,10 reduces tumor growth in a xenograft model of castration-resistant PCa (CRPC). This evidence concerns the gene PRKAA1 and neoplasm.